This section keeps you updated throughout the course of the TIMESPAN project.
Blog
-
29 January 2025
Global Insights: Harnessing Healthcare Data for ADHD Research in TIMESPAN
Read article …ADHD affects millions of individuals worldwide, yet how it is managed and treated can vary dramatically depending on where a patient lives. TIMESPAN is investigating that by harnessing a multi-national platform with healthcare data, paving the way for groundbreaking advancements in ADHD research and patient care.
-
24 January 2025
High genetic risk of ADHD is linked to health risks in adults without ADHD diagnosis: Insights from the Estonian Biobank
Read article …The Estonian Biobank (EstBB) is a large volunteer-based biobank, representing 20% of Estonia’s adult population. Linked to national electronic health records, it allows to study millions of genetic variants alongside up to 20 years of health data from over 212,000 participants. This provides a unique opportunity to uncover how genetics is associated with health outcomes.
-
9 January 2025
New systematic review on medication adherence in people with ADHD
Read article …Did you know that many kids with ADHD don’t stick to their medication? This can affect their long-term outcomes. Let’s talk about ways to improve adherence!
-
20 December 2024
WP4 paper finally submitted!
Read article …Finally submitted! 🎉 We are excited to soon share our research on how genetics contribute to medication discontinuation in ADHD.
Stimulant medications are the first-line treatment for ADHD, but over 50% of individuals discontinue them within two years. Our study, involving 18,362 individuals from the iPSYCH cohort, aimed to uncover the genetic factors behind this.
-
12 December 2024
New Insights on Long-Term ADHD Treatment and Its Link to Cardiovascular Disease
Read article …ADHD medications, particularly stimulants like methylphenidate and amphetamines, are widely recognized for their effectiveness in managing ADHD symptoms. However, they are also known to increase heart rate and blood pressure in the short term. With a growing number of adults being diagnosed and prescribed these medications for extended periods, questions about adherence patterns and safety, particularly potential risks of cardiovascular disease (CVD), have become increasingly relevant. As individuals with ADHD age and their risk for CVD naturally rises, robust evidence is crucial to guide safe and effective long-term treatment strategies.
-
4 December 2024
The value of pre-registration in psychiatric research.
Read article …The value of open science and reproducible research has been increasingly recognized in contemporary psychiatric research. It is also a key component of TIMESPAN. We aim for pre-registration of protocols on relevant platforms along with the final version of the R code (e.g., https://osf.io/). Our open science strategy also highlight the value of providing a description of how to access raw data for each data source (with online materials typically included in data sharing statements), and whenever possible, presenting aggregated raw data for all study variables in the appendix of publications.